Share：
Share this content in WeChat
X
[Chinese][PDF]114270
• Clinlcal Guidelines & Expert Consensu •
The interpretation of 2020 SCMR position paper on clinical indications for cardiovascular magnetic resonance
WANG Jiaxin  YANG Kai  ZHAO Shihua 

Cite this article as: Wang JX, Yang K, Zhao SH. The interpretation of 2020 SCMR position paper on clinical indications for cardiovascular magnetic resonance[J]. Chin J Magn Reson Imaging, 2021, 12(5): 85-89. DOI:10.12015/issn.1674-8034.2021.05.019.


[Abstract] Based on the latest research evidence and expert consensus, Society for Cardiovascular Magnetic Resonance (SCMR) published the Position Paper (2020) on clinical indications for cardiovascular magnetic resonance, including congenital heart disease, cardiomyopathy, myocarditis, acquired vascular disease, coronary artery disease, pericardial disease, cardiac masses, and valvular heart disease. Meanwhile, the usefulness of CMR in specific diseases was graded. We aim to interpret this position paper and provide relevant reference for clinical practice.
[Keywords] cardiovascular magnetic resonance；clinical indication；expert consensus

WANG Jiaxin   YANG Kai   ZHAO Shihua*  

Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing 100037, China

Zhao SH, E-mail: cjr.zhaoshihua@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS This work was part of Key Program of National Natural Science Foundation of China (No. 81930044). Key Program of International Cooperation and Exchanges NSFC (No. 81620108015).
Received  2021-01-12
Accepted  2021-03-25
DOI: 10.12015/issn.1674-8034.2021.05.019
Cite this article as: Wang JX, Yang K, Zhao SH. The interpretation of 2020 SCMR position paper on clinical indications for cardiovascular magnetic resonance[J]. Chin J Magn Reson Imaging, 2021, 12(5): 85-89. DOI:10.12015/issn.1674-8034.2021.05.019.

1
Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report[J]. J Cardiovasc Magn Reson, 2004, 6(4): 727-765. DOI: 10.1081/jcmr-200038581.
2
Leiner T, Bogaert J, Friedrich MG, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance[J]. J Cardiovasc Magn Reson, 2020, 22(1): 76. DOI: 10.1186/s12968-020-00682-4.
3
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease, Executive Summary, A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2019, 139(14): e637-e697. DOI: 10.1161/CIR.0000000000000602.
4
Orwat S, Diller GP, Kempny A, et al. Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot[J]. Heart, 2016, 102(3): 209-215. DOI: 10.1136/heartjnl-2015-308569.
5
Rathod RH, Prakash A, Kim YY, et al. Cardiac magnetic resonance parameters predict transplantation-free survival in patients with fontan circulation[J]. Circ Cardiovasc Imaging, 2014, 7(3): 502-509. DOI: 10.1161/CIRCIMAGING.113.001473.
6
Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume, A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)[J]. J Cardiovasc Magn Reson, 2017, 19(1): 75. DOI: 10.1186/s12968-017-0389-8.
7
Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy[J]. J Am Coll Cardiol, 2006, 48(10): 1977-1985. DOI: 10.1016/j.jacc.2006.07.049.
8
Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy[J]. Circulation, 2014, 130(6): 484-495. DOI: 10.1161/CIRCULATIONAHA.113.007094.
9
Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis[J]. Circulation, 2005, 111(2): 122-124. DOI: 10.1161/01.CIR.0000153623.02240.20.
10
Gandjbakhch E, Redheuil A, Pousset F, et al. Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia, JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2018, 72(7): 784-804. DOI: 10.1016/j.jacc.2018.05.065.
11
Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation, Expert Recommendations[J]. J Am Coll Cardiol, 2018, 72(24): 3158-3176. DOI: 10.1016/j.jacc.2018.09.072.
12
Weir-McCall JR, Yeap PM, Papagiorcopulo C, et al. Left ventricular noncompaction, anatomical phenotype or distinct cardiomyopathy?[J]. J Am Coll Cardiol, 2016, 68(20): 2157-2165. DOI: 10.1016/j.jacc.2016.08.054.
13
Ashrith G, Gupta D, Hanmer J, et al. Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy[J]. J Cardiovasc Magn Reson, 2014, 16(1): 64. DOI: 10.1186/s12968-014-0064-2.
14
Coleman GC, Shaw PW, Balfour PC, Jr, et al. Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis[J]. JACC Cardiovasc Imaging, 2017, 10(4): 411-420. DOI: 10.1016/j.jcmg.2016.05.009.
15
Edelman RR, Koktzoglou I. Noncontrast MR angiography, An update[J]. J Magn Reson Imaging, 2019, 49(2): 355-373. DOI: 10.1002/jmri.26288.
16
Chin AS, Willemink MJ, Kino A, et al. Acute limited intimal tears of the thoracic aorta[J]. J Am Coll Cardiol, 2018, 71(24): 2773-2785. DOI: 10.1016/j.jacc.2018.03.531.
17
Finn JP, Nguyen KL, Han F, et al. Cardiovascular MRI with ferumoxytol[J]. Clin Radiol, 2016, 71(8): 796-806. DOI: 10.1016/j.crad.2016.03.020.
18
Schwitter J, Arai AE. Assessment of cardiac ischaemia and viability, role of cardiovascular magnetic resonance[J]. Eur Heart J, 2011, 32(7): 799-809. DOI: 10.1093/eurheartj/ehq481.
19
Eitel I, Desch S, de Waha S, et al. Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction[J]. Heart, 2011, 97(24): 2038-2045. DOI: 10.1136/heartjnl-2011-300098.
20
Carrick D, Oldroyd KG, McEntegart M, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no-or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)[J]. J Am Coll Cardiol, 2014, 63(20): 2088-2098. DOI: 10.1016/j.jacc.2014.02.530.
21
Bulluck H, Fröhlich GM, Nicholas JM, et al. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction, The MINIMIZE STEMI trial[J]. Am Heart J, 2019, 211, 60-67. DOI: 10.1016/j.ahj.2019.02.005.
22
Foley JRJ, Kidambi A, Biglands JD, et al. A comparison of cardiovascular magnetic resonance and single photon emission computed tomography (SPECT) perfusion imaging in left main stem or equivalent coronary artery disease, a CE-MARC substudy[J]. J Cardiovasc Magn Reson, 2017, 19(1): 84. DOI: 10.1186/s12968-017-0398-7.
23
Nagel E, Greenwood JP, McCann GP, et al. Magnetic resonance perfusion or fractional flow reserve in coronary disease[J]. N Engl J Med, 2019, 380(25): 2418-2428. DOI: 10.1056/NEJMoa1716734.
24
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease[J]. N Engl J Med, 2020, 382(15): 1395-1407. DOI: 10.1056/NEJMoa1915922.
25
Dastidar AG, Baritussio A, De Garate E, et al. Prognostic role of cmr and conventional risk factors in myocardial infarction with nonobstructed coronary arteries[J]. JACC Cardiovasc Imaging, 2019, 12(10): 1973-1982. DOI: 10.1016/j.jcmg.2018.12.023.
26
Bogaert J, Francone M. Pericardial disease, value of CT and MR imaging[J]. Radiology, 2013, 267(2): 340-356. DOI: 10.1148/radiol.13121059.
27
Motwani M, Kidambi A, Herzog BA, et al. MR imaging of cardiac tumors and masses, a review of methods and clinical applications[J]. Radiology, 2013, 268(1): 26-43. DOI: 10.1148/radiol.13121239.

PREV Imaging findings of undifferentiated pleomorphic sarcoma of long bone (20 cases report)
NEXT Dural schwannoma: one case report
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn